Taking Actos can increase the risk of bladder cancer.

Has your doctor ever prescribed a drug for you and told you that you need to consider the benefits vs. risks of taking a medication?  There have been numerous lawsuits against drug manufacturers for not fully disclosing the risks of the medications they manufacture.

One such drug is Actos, which is prescribed to help manage Type II diabetes.

In some cases, Actos may worsen congestive heart failure and increase the risk of heart attacks.  According to the FDA, there is a 40 percent chance of increased risk of bladder cancer due to taking Actose. The longer a patient remains on Actos, the higher the risk of bladder and heart damage.

After an intense debate over the safety of the Type-2 diabetes drug Actos, the FDA has said that the heart risk warnings on Actos (pioglitazone) will now be surrounded by an emphatic black outline, known as a “black box warning,” due to the serious risk of adverse cardiovascular events, including heart attack, heart failure, and cardiovascular-related deaths. A black box warning is the strongest FDA-requested label change that can be added to a drug.

Our defective drug attorneys can help to answer your questions about health damages due to Actos and help determine if you may have a case.